Eledon Pharmaceuticals, Inc. ELDN
Regular-session close
After hours · Nov 20, 7:01 PM ET
- YTD
- +17.88%
- 1 year
- +28.06%
Held by funds
47 US ETFs and mutual funds hold ELDN · largest positions
- NJM 0.01% of fund $6.19M
- VTI 0.00% of fund $5.42M
- IWM 0.01% of fund $3.90M
- FSSNX 0.01% of fund $2.50M
- VXF 0.00% of fund $2.37M
- NAJ 0.02% of fund $2.08M
- IWO 0.01% of fund $1.39M
- VTWO 0.01% of fund $1.25M
- FSMAX 0.00% of fund $969.57K
- IJE 0.05% of fund $670.24K
- DFAS 0.00% of fund $465.45K
- IWC 0.04% of fund $448.62K
- MDSKX 0.01% of fund $373.82K
- BDSKX 0.00% of fund $254.65K
- VTWG 0.01% of fund $237.88K
- FECGX 0.01% of fund $231.48K
- GSSC 0.02% of fund $212.63K
- NLO 0.00% of fund $137.59K
- VBINX 0.00% of fund $120.67K
- VITPX 0.00% of fund $99.34K
Ownership
- Institutions 42.9%
- Insiders 0.04%
- Public and other holders 57.1%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| BVF Inc. | 10.53% | 6,293,282 | 26.37M | Sep 29, 2024 |
| Armistice Capital, LLC | 3.96% | 2,364,000 | 9.91M | Sep 29, 2024 |
| Vanguard Group Inc | 2.62% | 1,565,487 | 6.56M | Sep 29, 2024 |
| Schonfeld Strategic Advisors Llc | 2.51% | 1,500,000 | 6.29M | Sep 29, 2024 |
| Zimmer Partners, Lp | 2.40% | 1,434,727 | 6.01M | Sep 29, 2024 |
| Sphera Funds Management Ltd. | 2.17% | 1,297,321 | 5.44M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.93% | 1,152,398 | 4.83M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.64% | 385,138 | 1.61M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.37% | 220,431 | 923.61K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.15% | 87,894 | 368.27K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.09% | 56,617 | 237.22K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.08% | 48,878 | 204.80K | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs ELDN, and what each was last paid
David-Alexandre C. Gros, Chief Executive Officer & Non Independent DirectorAverage age 55
| Name | Title | Pay | Age |
|---|---|---|---|
| David-Alexandre C. Gros | Chief Executive Officer & Non Independent Director | $984K | 54 |
| Steven N. Perrin | President, Chief Scientific Officer & Non Independent Director | $792K | 60 |
| Paul Sean Little | Chief Financial Officer | $717K | 61 |
| Bryan E. Smith | General Counsel, Corporate Secretary & Chief Compliance Officer | $377K | 46 |
| Marina Escudero | Vice President & Head of Clinical Operations | — | — |
| John Herberger | Vice President of Technical Operations | — | — |
| David Hovland | Chief Regulatory Officer | — | — |
| Sepideh Habibi | VP and Head of Safety & Pharmacovigilance | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BVF PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | Purchase | May 8, 2024 | 0 |
